Literature DB >> 26563385

Cancer in ESRD: Clear on the Epidemiology, Hazy on the Mechanisms.

Wai H Lim1, Steven J Chadban2.   

Abstract

Entities:  

Keywords:  cancer; immunology; kidney disease; transplantation

Mesh：

Year:  2015        PMID： 26563385      PMCID： PMC4849837          DOI： 10.1681/ASN.2015091021

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  11 in total

1.  Cancer incidence before and after kidney transplantation.

Authors:  Claire M Vajdic; Stephen P McDonald; Margaret R E McCredie; Marina T van Leeuwen; John H Stewart; Matthew Law; Jeremy R Chapman; Angela C Webster; John M Kaldor; Andrew E Grulich
Journal:  JAMA       Date:  2006-12-20       Impact factor: 56.272

2.  Immune phenotype predicts risk for posttransplantation squamous cell carcinoma.

Authors:  Robert P Carroll; David San Segundo; Kevin Hollowood; Teresa Marafioti; Taane G Clark; Paul N Harden; Kathryn J Wood
Journal:  J Am Soc Nephrol       Date:  2010-01-28       Impact factor: 10.121

3.  The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B.

Authors:  Brian J McMahon
Journal:  Hepatol Int       Date:  2008-11-26       Impact factor: 6.047

4.  Cancer risk in patients on dialysis and after renal transplantation.

Authors:  S A Birkeland; H Løkkegaard; H H Storm
Journal:  Lancet       Date:  2000-05-27       Impact factor: 79.321

5.  Acute rejection, T-cell-depleting antibodies, and cancer after transplantation.

Authors:  Wai H Lim; Robin M Turner; Jeremy R Chapman; Maggie K M Ma; Angela C Webster; Jonathan C Craig; Germaine Wong
Journal:  Transplantation       Date:  2014-04-27       Impact factor: 4.939

6.  Cancer after kidney transplantation in the United States.

Authors:  Bertram L Kasiske; Jon J Snyder; David T Gilbertson; Changchun Wang
Journal:  Am J Transplant       Date:  2004-06       Impact factor: 8.086

Review 7.  Aspects of immune dysfunction in end-stage renal disease.

Authors:  Sawako Kato; Michal Chmielewski; Hirokazu Honda; Roberto Pecoits-Filho; Seiichi Matsuo; Yukio Yuzawa; Anders Tranaeus; Peter Stenvinkel; Bengt Lindholm
Journal:  Clin J Am Soc Nephrol       Date:  2008-08-13       Impact factor: 8.237

8.  The pattern of excess cancer in dialysis and transplantation.

Authors:  John H Stewart; Claire M Vajdic; Marina T van Leeuwen; Janaki Amin; Angela C Webster; Jeremy R Chapman; Stephen P McDonald; Andrew E Grulich; Margaret R E McCredie
Journal:  Nephrol Dial Transplant       Date:  2009-07-08       Impact factor: 5.992

9.  CD8+ Immunosenescence Predicts Post-Transplant Cutaneous Squamous Cell Carcinoma in High-Risk Patients.

Authors:  Matthew J Bottomley; Paul N Harden; Kathryn J Wood
Journal:  J Am Soc Nephrol       Date:  2015-11-12       Impact factor: 10.121

10.  Variation in Cancer Incidence among Patients with ESRD during Kidney Function and Nonfunction Intervals.

Authors:  Elizabeth L Yanik; Christina A Clarke; Jon J Snyder; Ruth M Pfeiffer; Eric A Engels
Journal:  J Am Soc Nephrol       Date:  2015-11-12       Impact factor: 14.978
View more
  2 in total

1.  The incidence of cancer recurrence and new cancer following commencement of dialysis.

Authors:  Wai H Lim; Esther Ooi; Aashi Pankaj; Armando Teixeira-Pinto; Yingxin Lin; David W Johnson; Carmel M Hawley; Andrea K Viecelli; Helen Pilmore; Matthew A Roberts; Christopher E Davies; Anoushka Krishnan; Germaine Wong
Journal:  Clin Kidney J       Date:  2022-06-02

2.  Long-term allograft and patient outcomes of kidney transplant recipients with and without incident cancer - a population cohort study.

Authors:  Wai H Lim; Sunil V Badve; Germaine Wong
Journal:  Oncotarget       Date:  2017-09-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.